196 related articles for article (PubMed ID: 25358405)
21. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.
LaCasse EC; Cherton-Horvat GG; Hewitt KE; Jerome LJ; Morris SJ; Kandimalla ER; Yu D; Wang H; Wang W; Zhang R; Agrawal S; Gillard JW; Durkin JP
Clin Cancer Res; 2006 Sep; 12(17):5231-41. PubMed ID: 16951243
[TBL] [Abstract][Full Text] [Related]
22. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
Nikolovska-Coleska Z; Xu L; Hu Z; Tomita Y; Li P; Roller PP; Wang R; Fang X; Guo R; Zhang M; Lippman ME; Yang D; Wang S
J Med Chem; 2004 May; 47(10):2430-40. PubMed ID: 15115387
[TBL] [Abstract][Full Text] [Related]
23. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
Kim DR; Park MY; Lee CS; Shim SH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
Cancer Gene Ther; 2011 Jul; 18(7):467-77. PubMed ID: 21455254
[TBL] [Abstract][Full Text] [Related]
24. Embelin induces apoptosis of human gastric carcinoma through inhibition of p38 MAPK and NF-κB signaling pathways.
Xu CL; Zheng B; Pei JH; Shen SJ; Wang JZ
Mol Med Rep; 2016 Jul; 14(1):307-12. PubMed ID: 27175982
[TBL] [Abstract][Full Text] [Related]
25. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
26. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
[TBL] [Abstract][Full Text] [Related]
27. XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.
Wehrkamp CJ; Gutwein AR; Natarajan SK; Phillippi MA; Mott JL
PLoS One; 2014; 9(3):e90238. PubMed ID: 24603802
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Effects of Mesenchymal Stem Cells and Various Agents on Apoptosis of Glioblastoma Cells.
Tanrikulu B; Ziyal I; Bayri Y
Turk Neurosurg; 2019; 29(1):26-32. PubMed ID: 29384188
[TBL] [Abstract][Full Text] [Related]
29. Embelin induces apoptosis in human glioma cells through inactivating NF-κB.
Park SY; Lim SL; Jang HJ; Lee JH; Um JY; Kim SH; Ahn KS; Lee SG
J Pharmacol Sci; 2013; 121(3):192-9. PubMed ID: 23514760
[TBL] [Abstract][Full Text] [Related]
30. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
[TBL] [Abstract][Full Text] [Related]
31. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
32. Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma.
Chu L; Gu J; He Z; Xiao T; Liu X
Cancer Biol Ther; 2006 Jun; 5(6):615-22. PubMed ID: 16627981
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
Shamimi-Noori S; Yeow WS; Ziauddin MF; Xin H; Tran TL; Xie J; Loehfelm A; Patel P; Yang J; Schrump DS; Fang BL; Nguyen DM
Cancer Gene Ther; 2008 Jun; 15(6):356-70. PubMed ID: 18309355
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
[TBL] [Abstract][Full Text] [Related]
36. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
Nakshatri H; Rice SE; Bhat-Nakshatri P
Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
[TBL] [Abstract][Full Text] [Related]
37. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
38. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
[TBL] [Abstract][Full Text] [Related]
39. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
40. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
Strekalova E; Malin D; Rajanala H; Cryns VL
Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
